Latest news
09-01-2024 - MRC Funding to Establish a Cancer Immunotherapy Response Research Platform
The Medical Research Council (MRC) and the Office for Life Sciences (OLS) are providing funding to develop a consortium-based, broad utility, deep genotyping and phenotyping platform - comprising of equipment, staff and expertise - that is capable of generating insights into patient response, adverse effects, and resistance to immunotherapy.
[...]